Overcoming psychological stress to injections for type 2 diabetes

Completed

• Conditions: Type 2 Diabetes; Nutritional, Metabolic, Endocrine; Type 2 Diabetes Mellitus

• Registration Number: ISRCTN16710901
• Lead Sponsor: lster University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-08-21
• Last Update Posted: 20 August 2018
• Study Completion: 2018-12-31

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

Phase 1
1. Type 2 diabetes =1 year.
2. Aged between 25 and 75
3. Commencement of insulin or GLP-1 receptor agonist within the previous 12 months from the date of the audit
4. Refusal of insulin or GLP-1 receptor agonist within the previous 12 months from the date of the audit

Phase 2
1. Type 2 diabetes diagnosed = 1 year
2. Aged between 25 and 75
3. HbA1c = 58 mmol/mol and =90 mmol/mol.
4. Transfer from oral hypoglycaemic treatment to injectable therapy judged appropriate by the consulting physician

Exclusion Criteria

Phase 2
1. Newly diagnosed type 2 diabetes < 1 year.
2. Patients who require immediate transfer to injectable therapy
3. HbA1c >90 mmol/mol
4. Patients undergoing retinal photocoagulation therapy or dialysis treatment
5. Those currently in receipt of psychiatry or clinical psychology input
6. Within 3 months of undergoing a major event including MI, stroke and major surgery
7. Within 3 months of diagnosis or treatment of a major coexisting medical condition

Study & Design

• Study Type: Interventional
• Study Design: Not specified